Regeneron Covid-19 Antibody Drug Reduced Risk of Hospitalization, Death by 70% in Late-Stage Trial

The drug was effective at a higher dose already in use and a lower dose, which the company said it would seek permission to start selling.

Meatpacking Industry Faces Overhaul Push in Washington

The push by lawmakers and regulators follows complaints about meat companies’...

Netflix Strikes Deal With Filmmaker Spielberg

Steven Spielberg’s production company, Amblin Partners, will make new films for...

Work Flexibility Is Hardly a Holy Grail

Surveys show many Americans aren’t eager to return to the office,...

Court Revives Challenge to California Mandate on Women Board Members

A federal appeals court said a shareholder may sue the state...